| Laura Elizabeth Conte, MS, CCC-SLP | |
|
1 Button Dr, Londonderry, NH 03053-3583 | |
| (603) 505-4242 | |
| Not Available |
| Full Name | Laura Elizabeth Conte |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1 Button Dr, Londonderry, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336659440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1483 (New Hampshire) | Primary |
| Provider Name | Fox Rehab-nh, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1811355373 PECOS PAC ID: 2466741293 Enrollment ID: O20160518002029 |
News Archive
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
A group of scientists in California is trying to develop a cheaper, less invasive way to spot the early stages of retinal damage from diabetic retinopathy, the leading cause of blindness in American adults, before it leads to blindness.
Leading pediatrics and sleep associations agree: Teens shouldn't start school so early. Yet University of Michigan research finds parents are split almost down the middle on whether they support delays in school start times that might permit their 13- to 17-year-olds to sleep later on school days.
A new study has identified a link between certain genes affected by testosterone and antibody responses to an influenza vaccine. The findings, published in Proceedings of the National Academy of Sciences, suggest that testosterone levels may partially explain why men often have weaker responses to vaccines than women.
An experimental drug called gaboxadol may soon help millions of bleary-eyed insomniacs get to sleep, and a multi-center team of U.S. scientists believes they've pinpointed just how the drug works.
› Verified 4 days ago
| Provider Name | Speak Easy Speech Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1316423197 PECOS PAC ID: 6406274133 Enrollment ID: O20200914000171 |
News Archive
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
A group of scientists in California is trying to develop a cheaper, less invasive way to spot the early stages of retinal damage from diabetic retinopathy, the leading cause of blindness in American adults, before it leads to blindness.
Leading pediatrics and sleep associations agree: Teens shouldn't start school so early. Yet University of Michigan research finds parents are split almost down the middle on whether they support delays in school start times that might permit their 13- to 17-year-olds to sleep later on school days.
A new study has identified a link between certain genes affected by testosterone and antibody responses to an influenza vaccine. The findings, published in Proceedings of the National Academy of Sciences, suggest that testosterone levels may partially explain why men often have weaker responses to vaccines than women.
An experimental drug called gaboxadol may soon help millions of bleary-eyed insomniacs get to sleep, and a multi-center team of U.S. scientists believes they've pinpointed just how the drug works.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Elizabeth Conte, MS, CCC-SLP 17 Lancelot Ave, Manchester, NH 03104-1419 Ph: () - | Laura Elizabeth Conte, MS, CCC-SLP 1 Button Dr, Londonderry, NH 03053-3583 Ph: (603) 505-4242 |
News Archive
SELLAS Life Sciences Group, a Swiss based, development-stage biopharmaceutical company with its main focus in developing innovative products for the treatment of various indications in Oncology and the Central Nervous System, today announced that it has signed an exclusive global collaboration and license agreement with TrojanTec Ltd, a UK-based Discovery Research and Development Company affiliated with Imperial College London, UK, for the development, marketing and commercialization of the innovative and proprietary TR-1 cancer therapeutic technology and drug.
A group of scientists in California is trying to develop a cheaper, less invasive way to spot the early stages of retinal damage from diabetic retinopathy, the leading cause of blindness in American adults, before it leads to blindness.
Leading pediatrics and sleep associations agree: Teens shouldn't start school so early. Yet University of Michigan research finds parents are split almost down the middle on whether they support delays in school start times that might permit their 13- to 17-year-olds to sleep later on school days.
A new study has identified a link between certain genes affected by testosterone and antibody responses to an influenza vaccine. The findings, published in Proceedings of the National Academy of Sciences, suggest that testosterone levels may partially explain why men often have weaker responses to vaccines than women.
An experimental drug called gaboxadol may soon help millions of bleary-eyed insomniacs get to sleep, and a multi-center team of U.S. scientists believes they've pinpointed just how the drug works.
› Verified 4 days ago
Alexandra Gatzoulis Demos, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Pillsbury Rd, Londonderry, NH 03053 Phone: 603-437-5855 Fax: 603-437-3709 | |
Jane Manning, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 150 Pillsbury Rd, Londonderry, NH 03053 Phone: 603-437-5855 | |
Kelley M Hayes, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Commons Dr # F, Suite 38, Londonderry, NH 03053 Phone: 603-437-3330 Fax: 603-437-0431 | |
Ms. Jennifer Thomas, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 324 Winding Pond Rd, Londonderry, NH 03053 Phone: 603-490-2382 | |
Mary Elizabeth Webster, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 80 Nashua Rd, Londonderry, NH 03053 Phone: 603-548-2188 | |
Janice Freethey O'shea, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 51 Shasta Dr, Londonderry, NH 03053 Phone: 603-548-2188 | |
Cheryl Clark, MSLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Gilcreast Rd Unit 201, Londonderry, NH 03053 Phone: 603-460-4923 |